<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Congenital syphilis: Clinical manifestations, evaluation, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Congenital syphilis: Clinical manifestations, evaluation, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Congenital syphilis: Clinical manifestations, evaluation, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Antonio C Arrieta, MD, FIDSA, FPIDS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 14, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H110901658"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Congenital syphilis occurs when the spirochete <em>Treponema pallidum</em> is transmitted from a pregnant individual to the fetus. Infection can result in stillbirth, prematurity, or a wide spectrum of clinical manifestations; only severe cases are clinically apparent at birth [<a href="#rid1">1</a>].</p><p>The clinical features, evaluation, and diagnosis of congenital syphilis will be discussed here. The management and prevention of congenital syphilis, syphilis in pregnancy, and acquired syphilis are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Clinical manifestations'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7597.html" rel="external">"Syphilis: Treatment and monitoring"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7599.html" rel="external">"Neurosyphilis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing"</a>.)</p><p></p><p class="headingAnchor" id="H28809236"><span class="h1">EPIDEMIOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence</strong> – Congenital syphilis is a significant public health problem, complicating an estimated one million pregnancies per year throughout the world [<a href="#rid2">2,3</a>]. The incidence of congenital syphilis reflects the rate of syphilis in women of childbearing age [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent1">Most cases develop because the mother received no prenatal care or insufficient treatment for syphilis before or during pregnancy  (<a class="graphic graphic_table graphicRef73418" href="/d/graphic/73418.html" rel="external">table 1</a>) [<a href="#rid5">5-7</a>]. Among women with untreated early syphilis, 40 percent of pregnancies result in spontaneous abortion [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Prevalence'</a>.)</p><p></p><p class="bulletIndent1">Rates of congenital syphilis in the United States have risen steadily since 2012 [<a href="#rid9">9,10</a>]. In 2020, there were a total of 2152 reported cases of congenital syphilis in the United States, including 122 syphilitic stillbirths and 29 infant deaths [<a href="#rid10">10,11</a>]. The 2020 case rate (57 cases per 100,000 live births) represents the highest reported rate since 1991. As is expected, the increase in rates of congenital syphilis parallels increases in primary and secondary syphilis among women during this period  (<a class="graphic graphic_figure graphicRef55877" href="/d/graphic/55877.html" rel="external">figure 1</a>) [<a href="#rid9">9,10,12</a>].</p><p></p><p class="bulletIndent1">Syphilis in pregnancy is commonly associated with adverse pregnancy outcomes (fetal loss, stillbirth, neonatal death, prematurity, and low birth weight), as discussed separately. (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Potential adverse pregnancy outcomes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Poor access to prenatal care is an important risk factor for congenital syphilis. Among the 458 cases of congenital syphilis reported to the Centers for Disease Control and Prevention (CDC) in 2014, nearly one-quarter were born to mothers who did not receive prenatal care [<a href="#rid9">9</a>]. Among the 314 cases in which the mother received prenatal care, 135 (43 percent) received no treatment for syphilis during the pregnancy and 94 (30 percent) received inadequate treatment. </p><p></p><p class="bulletIndent1">Social vulnerabilities including homelessness, substance abuse, and incarceration were found to be barriers to timely diagnosis and treatment of syphilis in pregnant women in a review of congenital cases in Indiana [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1">The rate of congenital syphilis is increased among infants born to mothers with human immunodeficiency virus (HIV) infection. However, the contribution of maternal coinfection with syphilis and HIV to vertical transmission of either syphilis or HIV is not completely understood. (See  <a class="medical medical_review" href="/d/html/7600.html" rel="external">"Syphilis in patients with HIV", section on 'Effect of syphilis on HIV'</a>.)</p><p></p><p class="bulletIndent1">The rate of congenital syphilis is generally low among children adopted internationally; however, it is relatively increased among those adopted from Africa  (<a class="graphic graphic_table graphicRef87688" href="/d/graphic/87688.html" rel="external">table 2</a>). Given the difficulty in confirming adequate treatment/treatment response of the birth mother and the risk of long-term sequelae in untreated children, we recommend screening international adoptees for congenital syphilis (regardless of the country of origin). (See  <a class="medical medical_review" href="/d/html/16709.html" rel="external">"International adoption: Infectious disease aspects", section on 'Syphilis'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Missed opportunities</strong> – The most common missed opportunity for prevention of congenital syphilis is lack of adequate maternal treatment despite a timely diagnosis, which accounts for approximately 30 to 40 percent of cases [<a href="#rid9">9,10</a>]. Other missed opportunities include lack of prenatal care (20 to 30 percent of cases), failure to perform timely syphilis testing (10 to 15 percent of cases), and late identification of seroconversion during pregnancy (approximately 10 percent of cases) [<a href="#rid10">10,11,14</a>]. In studies conducted in New York, Florida, and Louisiana, repeat early testing during the third trimester is an effective intervention for preventing congenital syphilis [<a href="#rid15">15,16</a>]. </p><p></p><p class="headingAnchor" id="H110903715"><span class="h1">TRANSMISSION</span><span class="headingEndMark"> — </span>Humans are the only natural host of <em>T. pallidum</em> [<a href="#rid17">17</a>]. Congenital syphilis generally is acquired through transplacental transmission during maternal spirochetemia or, occasionally, through direct contact with an infectious lesion during birth [<a href="#rid18">18-20</a>]. (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Vertical transmission (congenital syphilis)'</a>.)</p><p>Transplacental transmission of <em>T. pallidum</em> can occur at any time during gestation but occurs with increasing frequency as gestation advances. Women with untreated primary or secondary syphilis are more likely to transmit syphilis to their fetuses than women with latent disease (60 to 90 versus 40 percent in early latent and &lt;10 percent in late latent syphilis) [<a href="#rid21">21,22</a>]. The risk of transmission decreases with increasing time since primary or secondary infection and is only 2 percent after four years.</p><p><em>T. pallidum</em> is not transferred in breast milk, but transmission may occur if the mother has an infectious lesion (eg, chancre) on her breast [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H28809243"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>At the onset of congenital syphilis, <em>T. pallidum</em> is liberated directly into the circulation of the fetus, resulting in spirochetemia with widespread dissemination to almost all organs. Clinical manifestations are the result of inflammation in the affected organs. Bones, liver, pancreas, intestine, kidney, and spleen are most frequently and severely involved. The severity of illness is variable and can range from isolated laboratory or radiographic abnormalities to fulminant involvement of multiple organ systems. Overt infection can manifest in the fetus, the newborn, or later in childhood (if the newborn/infant is not treated appropriately and timely) [<a href="#rid24">24</a>].</p><p>The pathophysiology of and immune response to acquired syphilis infection are discussed separately. (See  <a class="medical medical_review" href="/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV"</a>.)</p><p class="headingAnchor" id="H1323467086"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H28809272"><span class="h2">Early congenital syphilis</span><span class="headingEndMark"> — </span>Early congenital syphilis is arbitrarily defined by clinical manifestations with onset before two years of age [<a href="#rid25">25</a>]. </p><p class="headingAnchor" id="H114346591"><span class="h3">Clinical findings</span><span class="headingEndMark"> — </span>Clinical manifestations in untreated infants usually appear by three months of age, most often by five weeks [<a href="#rid25">25,26</a>].</p><p>Approximately 60 to 90 percent of live-born neonates with congenital syphilis are asymptomatic at birth [<a href="#rid9">9,27</a>]. The presence of signs at birth depends upon the timing of intrauterine infection and treatment [<a href="#rid17">17</a>]. Among symptomatic infants, the most common findings include [<a href="#rid9">9,28</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Hepatomegaly</p><p class="bulletIndent1"><span class="glyph">●</span>Jaundice</p><p class="bulletIndent1"><span class="glyph">●</span>Nasal discharge ("snuffles")</p><p class="bulletIndent1"><span class="glyph">●</span>Rash</p><p class="bulletIndent1"><span class="glyph">●</span>Generalized lymphadenopathy</p><p class="bulletIndent1"><span class="glyph">●</span>Skeletal abnormalities</p><p></p><p>Clinical manifestations of early syphilis are varied and unpredictable  (<a class="graphic graphic_table graphicRef67809" href="/d/graphic/67809.html" rel="external">table 3</a>) [<a href="#rid1">1,17,23,25,29,30</a>]. Common clinical findings are reviewed here:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placenta and umbilical cord</strong> – The placenta of neonates with congenital syphilis is often large, thick, and pale. The umbilical cord is edematous and may resemble a "barber's pole" with spiral stripes of red and light blue discoloration alternating with streaks of chalky white. It may be significantly inflamed with abscess-like foci of necrosis within Wharton jelly, centered around the umbilical vessels (necrotizing funisitis) [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/d/html/5009.html" rel="external">"Care of the umbilicus and management of umbilical disorders", section on 'Funisitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hepatomegaly</strong> – Hepatomegaly occurs in almost all infants with congenital syphilis [<a href="#rid7">7,23</a>]. Hepatomegaly may or may not be associated with splenomegaly, but isolated splenomegaly does not occur. When noted on fetal ultrasonography, hepatomegaly may indicate failure of maternal treatment to prevent fetal infection [<a href="#rid33">33</a>]. Hepatomegaly is associated with jaundice and cholestasis. Spirochetes can be seen on liver biopsy (if one is performed). (See <a class="local">'Laboratory abnormalities'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rhinitis </strong>–<strong> </strong>Syphilitic rhinitis ("snuffles")  (<a class="graphic graphic_picture graphicRef65509" href="/d/graphic/65509.html" rel="external">picture 1</a>) may herald the onset of congenital syphilis. It usually develops during the first week after birth and seldom after the third month. The nasal discharge is white and may be bloody (secondary to mucosal erosion) or purulent if there is secondary bacterial infection. It is more severe and persistent than the nasal discharge typical of most childhood viral upper respiratory infections. The nasal discharge contains spirochetes, is contagious, and can transmit infection by direct contact. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rash </strong>–<strong> </strong>The rash of congenital syphilis usually appears one to two weeks after the rhinitis. It is maculopapular and consists of small, initially red or pink spots. The lesions may occur anywhere, but are more prominent on the back, buttocks, posterior thighs, palms, and soles  (<a class="graphic graphic_picture graphicRef81352" href="/d/graphic/81352.html" rel="external">picture 2</a>). The rash generally progresses over one to three weeks, followed by desquamation and crusting. As it fades, the lesions become dusky red or copper-colored, and the pigmentation may persist. If present at birth, the rash may be widely disseminated and bullous (pemphigus syphiliticus). Ulcerative lesions and bullous fluid contain spirochetes, are contagious, and can transmit infection by direct contact. </p><p></p><p class="bulletIndent1">Other characteristic, but uncommon, cutaneous lesions of congenital syphilis include fissures, mucous patches, and condylomata lata  (<a class="graphic graphic_picture graphicRef95629 graphicRef83522" href="/d/graphic/95629.html" rel="external">picture 3A-B</a>). The fissures occur around the lips, nares, and anus. They bleed easily and heal with scarring. The mucous patches may occur on any mucous membrane, particularly those in the mouth and genitalia. Condylomata lata are flat, wart-like, moist lesions around the mouth, nares, anus, and other areas of the skin where there is moisture or friction  (<a class="graphic graphic_picture graphicRef95629 graphicRef83522" href="/d/graphic/95629.html" rel="external">picture 3A-B</a>). They contain spirochetes and can transmit infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Generalized lymphadenopathy</strong> – Generalized, nontender lymphadenopathy is a common manifestation. Palpable epitrochlear lymphadenopathy in an infant is highly suggestive of congenital syphilis [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other manifestations</strong> – Other manifestations of early congenital syphilis may include [<a href="#rid1">1,7,17,23,25,29,30</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonimmune fetal hydrops</p><p class="bulletIndent2"><span class="glyph">•</span>Fever (may be more prominent in infants born to mothers who are affected late in pregnancy and whose serology is negative at delivery)</p><p class="bulletIndent2"><span class="glyph">•</span>Myocarditis</p><p class="bulletIndent2"><span class="glyph">•</span>Pneumonia</p><p class="bulletIndent2"><span class="glyph">•</span>Failure to move an extremity secondary to painful periostitis ("pseudoparalysis of Parrot")</p><p class="bulletIndent2"><span class="glyph">•</span>Sepsis due to other bacteria (eg, <em>Escherichia coli</em>, group B streptococci, <em>Yersinia</em> species) (see  <a class="medical medical_review" href="/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Ophthalmologic manifestations – Loss of eyebrows, chorioretinitis, uveitis, cataract, glaucoma, and chancre of the eyelid</p><p class="bulletIndent2"><span class="glyph">•</span>Gastrointestinal manifestations – Rectal bleeding (from ileitis), necrotizing enterocolitis, malabsorption</p><p class="bulletIndent2"><span class="glyph">•</span>Nephrotic syndrome (immune complex mediated; responsive to penicillin) [<a href="#rid34">34-37</a>] (see  <a class="medical medical_review" href="/d/html/6137.html" rel="external">"Congenital nephrotic syndrome", section on 'Infectious causes'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central nervous system (CNS) findings</strong> – CNS syphilis in children with congenital infection may be asymptomatic or symptomatic. </p><p></p><p class="bulletIndent1">Asymptomatic CNS syphilis is indicated by abnormalities in the cerebrospinal fluid (CSF) (see <a class="local">'Laboratory abnormalities'</a> below). Asymptomatic CNS syphilis occurs in approximately 40 percent of infants who have clinical, laboratory, or radiographic abnormalities of congenital syphilis, but is infrequent in infants without such manifestations [<a href="#rid17">17,38-42</a>].</p><p></p><p class="bulletIndent1">Symptomatic CNS involvement is rare among infants with congenital syphilis in the era of penicillin therapy but may develop from ongoing dissemination in infants who are not treated in the neonatal period [<a href="#rid17">17</a>]. Symptomatic CNS syphilis in infants has two overlapping presentations: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute syphilitic leptomeningitis typically manifests during the first year of life, usually between three and six months. The clinical findings are suggestive of bacterial meningitis (eg, vomiting, bulging fontanelle, increased head circumference, splitting of the cranial sutures), but the CSF findings are consistent with aseptic meningitis (predominance of mononuclear cells, modest increase in protein, normal glucose) [<a href="#rid17">17,23</a>]. Congenital syphilis should be considered in febrile infants with unexplained aseptic meningitis. Acute syphilitic leptomeningitis generally responds to parenteral penicillin therapy. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on 'Penicillin therapy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chronic meningovascular syphilis typically manifests toward the end of the first year [<a href="#rid17">17</a>]. The clinical findings include signs of progressive hydrocephalus, cranial nerve palsies, papilledema, optic atrophy, neurodevelopmental regression, and seizures. Syphilitic endarteritis may cause cerebral infarction in the second year of life.</p><p></p><p class="bulletIndent1">In addition, pituitary gland involvement may manifest with persistent hypoglycemia or diabetes insipidus [<a href="#rid43">43,44</a>].</p><p></p><p class="headingAnchor" id="H138792840"><span class="h3">Radiographic abnormalities</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bony abnormalities</strong> – Bony abnormalities are a common manifestation of early congenital syphilis (occurring in 60 to 80 percent of cases) and may be the sole manifestation in infants born to mothers with untreated syphilis [<a href="#rid45">45,46</a>]. The changes usually are present at birth but may appear in the first few weeks after birth. Bone abnormalities may be associated with pathologic fractures or pain, which may limit movement of the involved extremity, giving the appearance of paralysis ("pseudoparalysis of Parrot") [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1">The radiographic abnormalities characteristically are bilateral, symmetric, and polyostotic; the femur, humerus, and tibia are most frequently involved. Findings may include [<a href="#rid47">47-49</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Metaphyseal lucent bands (this finding may occur in response to other systemic illnesses)  (<a class="graphic graphic_diagnosticimage graphicRef62990" href="/d/graphic/62990.html" rel="external">image 1A</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symmetric localized demineralization and osseous destruction of the medial portion of the proximal tibial metaphysis (Wimberger sign), which also may occur in neonatal hyperparathyroidism and osteomyelitis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Metaphyseal serration ("sawtooth metaphysis").</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Diaphyseal periostitis with new bone formation (may occur in other conditions including nonaccidental trauma)  (<a class="graphic graphic_diagnosticimage graphicRef72752" href="/d/graphic/72752.html" rel="external">image 1B</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Irregular areas of increased density and rarefaction ("moth-eaten" appearance)  (<a class="graphic graphic_diagnosticimage graphicRef74323" href="/d/graphic/74323.html" rel="external">image 1C</a> and <a class="graphic graphic_diagnosticimage graphicRef52714" href="/d/graphic/52714.html" rel="external">image 1D</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary findings</strong> – Complete opacification of both lung fields ("pneumonia alba") is the classic radiographic appearance of pneumonia in infants with congenital syphilis. However, a fluffy, diffuse infiltrate involving all lung areas is more common in the era of penicillin therapy.</p><p></p><p class="headingAnchor" id="H138792874"><span class="h3">Laboratory abnormalities</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hematologic studies</strong> – Hematologic abnormalities of early congenital syphilis may include [<a href="#rid7">7,50,51</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anemia – In the newborn period, the characteristic finding is direct antiglobulin test (DAT; also called Coombs) negative hemolytic anemia. Hemolysis is often accompanied by cryoglobulinemia, immune complex formation, and macroglobulinemia [<a href="#rid23">23</a>]. It may last for weeks. Chronic DAT-negative anemia may persist beyond the neonatal period and may be accentuated by the onset of physiologic anemia of infancy. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombocytopenia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Leukopenia or leukocytosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormal liver function tests (LFT)</strong> – This may include elevated aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and direct bilirubin. Delayed prothrombin time may be seen if liver synthetic function is impaired. LFT abnormalities may be exacerbated by penicillin therapy before improving [<a href="#rid52">52</a>]. Transaminitis generally resolves slowly, even after adequate therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CSF abnormalities</strong> – Findings that indicate CNS involvement include [<a href="#rid1">1,7,53,54</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Reactive CSF VDRL</strong> – A reactive CSF Venereal Disease Research Laboratory (VDRL) test supports the diagnosis of CNS syphilis. However, false positives can occur from maternal nontreponemal antibodies crossing the placenta and diffusing into the fetal CSF or through contamination of the CSF with blood from a traumatic lumbar puncture. False negatives can also occur. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>CSF pleocytosis</strong> – The CSF white blood cell (WBC) count can be difficult to interpret since normal values in newborns vary by gestational and postnatal age. Some experts define CSF pleocytosis as &gt;5 WBCs/microL [<a href="#rid1">1,42</a>]; others accept values as high as 20 WBCs/microL to be normal [<a href="#rid55">55</a>]. We generally consider a CSF WBC &gt;15/microL in a term newborn to be abnormal; a higher threshold is used in preterm neonates. After the age of one month, CSF pleocytosis is defined as WBC &gt;5 microL. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Elevated CSF protein</strong> – As with WBCs, the definition of elevated CSF protein in newborns is variably defined, ranging from &gt;45 mg/dL to as high as 150 mg/dL (or 170 mg/dL in premature infants). After the age of one month, elevated CSF protein is defined as ≥45 mg/dL. </p><p></p><p class="bulletIndent1">However, none of these findings is highly sensitive or specific [<a href="#rid40">40,42</a>]. In an observational study that used the rabbit infectivity test as the reference standard for identification of spirochetes in the CSF, the sensitivity and specificity of these findings were as follows [<a href="#rid40">40</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reactive CSF VDRL – Sensitivity 54 percent, specificity 90 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Elevated CSF WBC count – Sensitivity 38 percent, specificity 88 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Elevated CSF protein – Sensitivity 56 percent, specificity 78 percent</p><p></p><p class="bulletIndent1">Examination of the CSF for <em>T. pallidum </em>deoxyribonucleic acid (DNA) by polymerase chain reaction (PCR) may prove more useful for definitive diagnosis of congenital neurosyphilis [<a href="#rid18">18,40,41</a>], but this test is not widely available. (See <a class="local">'Other tests'</a> below.)</p><p></p><p class="headingAnchor" id="H28809349"><span class="h2">Late congenital syphilis</span><span class="headingEndMark"> — </span>Late congenital syphilis is arbitrarily defined by clinical manifestations with onset after two years of age [<a href="#rid25">25</a>]. Manifestations of late congenital syphilis are related to scarring or persistent inflammation from early infection and are characterized by gumma formation in various tissues [<a href="#rid56">56</a>]. Late congenital syphilis develops in approximately 40 percent of infants born to women with untreated syphilis during pregnancy. Most manifestations of late congenital syphilis are prevented by appropriate treatment of the mother during pregnancy or by treatment of the infant within the first three months of life [<a href="#rid57">57,58</a>]. However, other manifestations (eg, keratitis, saber shins) may occur or progress despite appropriate therapy [<a href="#rid59">59</a>].</p><p>Manifestations of late congenital syphilis include  (<a class="graphic graphic_table graphicRef81529" href="/d/graphic/81529.html" rel="external">table 4</a>) [<a href="#rid1">1,23,58,60,61</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Facial features – Frontal bossing  (<a class="graphic graphic_picture graphicRef69781" href="/d/graphic/69781.html" rel="external">picture 4</a>), saddle nose, short maxilla, protuberant mandible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ophthalmologic – Interstitial keratitis  (<a class="graphic graphic_picture graphicRef52740" href="/d/graphic/52740.html" rel="external">picture 5</a>) (bilateral, usually occurs around puberty but can occur anytime between 4 and 30 years), secondary glaucoma, corneal scarring, optic atrophy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hearing – Sensorineural hearing loss associated with late congenital syphilis typically develops suddenly at 8 to 10 years of age and often accompanies interstitial keratitis. The higher frequencies are affected first; normal conversational tones are affected later. Syphilis-associated hearing loss may respond to long-term glucocorticoid therapy [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Oropharynx – Hutchinson teeth (hypoplastic, notched, widely spaced permanent teeth [upper central incisors most commonly affected]  (<a class="graphic graphic_picture graphicRef58454" href="/d/graphic/58454.html" rel="external">picture 6</a>); before eruption, Hutchinson teeth are visible on dental radiographs), mulberry molars (maldevelopment of the cusps of the first molars)  (<a class="graphic graphic_picture graphicRef71291" href="/d/graphic/71291.html" rel="external">picture 7</a>), and perforation of the hard palate (virtually pathognomonic for congenital syphilis)  (<a class="graphic graphic_picture graphicRef58887" href="/d/graphic/58887.html" rel="external">picture 8</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cutaneous – Rhagades (perioral fissures or a cluster of scars radiating around the mouth)  (<a class="graphic graphic_picture graphicRef80868" href="/d/graphic/80868.html" rel="external">picture 9</a>), gummas (granulomatous inflammatory response to spirochetes) in the skin or mucous membranes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic – Intellectual disability, arrested hydrocephalus, cranial nerve palsies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skeletal – Anterior bowing of the shins ("saber shins")  (<a class="graphic graphic_picture graphicRef81604" href="/d/graphic/81604.html" rel="external">picture 10</a>), enlargement of the sternoclavicular portion of the clavicle (Higoumenakis sign), painless arthritis of the knees ("Clutton joints")  (<a class="graphic graphic_picture graphicRef78286" href="/d/graphic/78286.html" rel="external">picture 11</a>), and, rarely, other joints.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hematologic – Paroxysmal cold hemoglobinuria. (See  <a class="medical medical_review" href="/d/html/7085.html" rel="external">"Paroxysmal cold hemoglobinuria"</a>.)</p><p></p><p>Among these manifestations, Hutchinson triad (Hutchinson teeth, interstitial keratitis, and sensorineural hearing loss), mulberry molars, and Clutton joints are relatively specific for congenital syphilis [<a href="#rid23">23,60</a>].</p><p class="headingAnchor" id="H3329466022"><span class="h1">EVALUATION AND DIAGNOSIS</span><span class="headingEndMark"> — </span>The vagaries of the maternal history of syphilis and signs or lack of signs in the newborn in combination with the potential consequences of delayed or missed diagnosis of congenital syphilis demand a "safety first" approach to both diagnosis and treatment [<a href="#rid10">10,63</a>]. The United States Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) Committee on Infectious Diseases provide guidelines for the evaluation and management of congenital syphilis [<a href="#rid53">53,54</a>]. Similar <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F249572%2F9789241549806-webannexD-eng.pdf%3Fsequence%3D2&amp;token=1ljOdxri1XD60%2Fp8hu26lkqgnnExaEGykOhhKWb%2BIbNJUL1MOPehYay1o87VVc9EH96sTET%2Fn%2Bt6z0rGYNmsvr2B%2BdvM74tSjar1aintmrf0%2FAdgrDU2kympRNKKIsTW&amp;TOPIC_ID=14428" target="_blank">guidelines</a> are provided by the World Health Organization [<a href="#rid64">64</a>]. (See <a class="local">'Society guideline links'</a> below.)</p><p>The CDC and AAP guidelines continue to recommend that maternal samples be screened according to the traditional algorithm (ie, a nontreponemal test followed when positive by a confirmatory treponemal test) [<a href="#rid53">53,54</a>]. However, both organizations recognize that due to practical and cost considerations, many antenatal care providers screen pregnant individuals in reverse sequence (testing initially for syphilis antibodies, typically by enzyme immunoassay [EIA] or chemiluminescence immunoassay [CIA], followed by nontreponemal test if EIA/CIA is positive). The CDC has provided guidance for interpreting results, which is particularly important when the initial EIA/CIA treponemal test is discordant with the subsequent nontreponemal test [<a href="#rid65">65</a>]. Interpretation of maternal screening results with the traditional and reverse sequence screening algorithms is discussed separately. (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing", section on 'Serologic testing algorithms'</a>.)</p><p class="headingAnchor" id="H2095432207"><span class="h2">Clinical suspicion</span><span class="headingEndMark"> — </span>The diagnosis of congenital syphilis may be suspected based upon <strong>any</strong> of the following: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maternal syphilis during pregnancy</strong> – Evaluation for early congenital syphilis is warranted in all newborns born to mothers who have reactive nontreponemal and treponemal tests for syphilis during pregnancy. (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maternal syphilis during first three months after delivery</strong> – This includes infants born to women who are identified clinically or through contact tracing [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Concerning clinical findings</strong> – The possibility of congenital syphilis should be considered in all newborn infants with concerning clinical findings. This is particularly important when there is prior history or risk factors for syphilis in the mother (eg, inadequate prenatal care, other sexually transmitted diseases, homelessness or unstable housing, drug abuse, incarceration, having sex in conjunction with drug use or transactional sex). Maternal risk factors for syphilis are discussed separately. (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent1">Clinical findings that may raise concern for congenital syphilis in this setting include the following; however, these are nonspecific findings:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained prematurity (&lt;37 weeks gestation)</p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained hydrops fetalis</p><p class="bulletIndent2"><span class="glyph">•</span>Enlarged placenta</p><p class="bulletIndent2"><span class="glyph">•</span>Failure to move an extremity ("pseudoparalysis")</p><p class="bulletIndent2"><span class="glyph">•</span>Persistent rhinitis  (<a class="graphic graphic_picture graphicRef65509" href="/d/graphic/65509.html" rel="external">picture 1</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Maculopapular or papulosquamous rash  (<a class="graphic graphic_picture graphicRef81352" href="/d/graphic/81352.html" rel="external">picture 2</a>), particularly in the diaper area, palms, and soles</p><p class="bulletIndent2"><span class="glyph">•</span>Jaundice, hepatomegaly</p><p class="bulletIndent2"><span class="glyph">•</span>Neonatal pneumonia</p><p class="bulletIndent2"><span class="glyph">•</span>Generalized lymphadenopathy</p><p class="bulletIndent2"><span class="glyph">•</span>Anemia (direct antiglobulin test negative)</p><p class="bulletIndent2"><span class="glyph">•</span>Thrombocytopenia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infants and children who are adopted internationally </strong>– This is discussed separately. (See  <a class="medical medical_review" href="/d/html/16709.html" rel="external">"International adoption: Infectious disease aspects", section on 'Syphilis'</a>.)</p><p></p><p class="headingAnchor" id="H616558624"><span class="h2">Initial evaluation</span></p><p class="headingAnchor" id="H3661714292"><span class="h3">Neonates</span><span class="headingEndMark"> — </span>Diagnostic testing for congenital syphilis is warranted in all newborn infants whose mothers have reactive nontreponemal and treponemal tests for syphilis. For mothers screened with the traditional approach, the treponemal test is necessary to exclude a false positive nontreponemal result. When reverse sequencing is used, the nontreponemal test is still necessary for comparison with the mother's result and for monitoring of treatment success (two nontreponemal tests are needed when there is discordance between syphilis antibody and nontreponemal test during reverse sequencing). (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Diagnosis'</a>.)</p><p>The initial evaluation of newborns born to mothers who tested positive for syphilis during pregnancy should include <strong>all</strong> of the following  (<a class="graphic graphic_algorithm graphicRef140138" href="/d/graphic/140138.html" rel="external">algorithm 1</a>) [<a href="#rid53">53,54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Quantitative nontreponemal test (Venereal Disease Research Laboratory [VDRL] test or rapid plasma reagin [RPR]) on infant serum (umbilical cord blood should <strong>not</strong> be used for testing since false positive results can occur if the sample is contaminated with maternal blood). The nontreponemal test performed in the newborn should be the same as was used for the mother so that the newborn's titers can be compared with the mother's. (See <a class="local">'Nontreponemal tests'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination for evidence of congenital syphilis  (<a class="graphic graphic_table graphicRef67809" href="/d/graphic/67809.html" rel="external">table 3</a>). (See <a class="local">'Clinical findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Where available, testing for <em>T. pallidum</em> with direct fluorescent antibody (DFA) staining, darkfield microscopic examination, and/or polymerase chain reaction (PCR) can be performed on any concerning skin lesions or nasal discharge. However, these tests are not available in many clinical settings. (See <a class="local">'Other tests'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If possible, pathologic examination of the placenta or umbilical cord can be performed using specific fluorescent antitreponemal antibody staining [<a href="#rid20">20,32,66</a>]. Characteristic histopathologic features are described separately. (See  <a class="medical medical_review" href="/d/html/5009.html" rel="external">"Care of the umbilicus and management of umbilical disorders", section on 'Funisitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Additional evaluation should be performed based upon the findings from the initial evaluation, as discussed below. (See <a class="local">'Evaluation for extent of organ involvement'</a> below.)</p><p></p><p class="headingAnchor" id="H2822682118"><span class="h3">Older than one month</span><span class="headingEndMark"> — </span>The initial evaluation of infants and children older than one month of age with clinical, radiographic, or laboratory manifestations compatible with congenital syphilis should include [<a href="#rid53">53,54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Quantitative VDRL or RPR (see <a class="local">'Nontreponemal tests'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination</p><p class="bulletIndent1"><span class="glyph">●</span>Darkfield microscopic examination or DFA staining of concerning skin lesions or nasal discharge (if available) (see <a class="local">'Other tests'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebrospinal fluid (CSF) analysis for VDRL, white blood cell (WBC) count, and protein measurement (see <a class="local">'Lumbar puncture'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count (CBC) with differential and platelet count</p><p class="bulletIndent1"><span class="glyph">●</span>Liver function tests</p><p class="bulletIndent1"><span class="glyph">●</span>Skeletal radiographs (see <a class="local">'Skeletal survey'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Hearing evaluation (see <a class="local">'Hearing evaluation'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Ophthalmologic examination (see <a class="local">'Eye examination'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Other tests as clinically indicated (eg, chest radiograph, abdominal ultrasonography, and neuroimaging studies) (see <a class="local">'Other assessments'</a> below)</p><p></p><p>Infants and children who are found to have reactive serologic tests for syphilis when they are older than one month of age should have maternal serology and records reviewed to assess whether the child has congenital or acquired syphilis, although this distinction may be difficult [<a href="#rid1">1,24</a>]. </p><p>In addition to the above testing, any child at risk for congenital syphilis should also undergo testing for HIV [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/6006.html" rel="external">"Diagnostic testing for HIV infection in infants and children younger than 18 months"</a> and  <a class="medical medical_review" href="/d/html/3736.html" rel="external">"Screening and diagnostic testing for HIV infection"</a>.)</p><p>The distinction between congenital and acquired syphilis can be difficult and ultimately may rest upon maternal history and clinical judgment [<a href="#rid1">1</a>]. CSF and CBC abnormalities may occur in both congenital and acquired syphilis, but abnormalities on long-bone radiographs are strongly supportive of congenital syphilis. (See <a class="local">'Congenital versus acquired syphilis'</a> below and <a class="local">'Radiographic abnormalities'</a> above.)</p><p>In a young child, the possibility of sexual abuse should be considered as a cause of acquired syphilis [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a>.)</p><p>Children who are diagnosed with syphilis after one month of age (including those with previously untreated congenital syphilis) require parenteral penicillin therapy, as discussed separately. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on '&gt;1 month of age'</a>.)</p><p class="headingAnchor" id="H3975074252"><span class="h3">Evaluation of siblings</span><span class="headingEndMark"> — </span>Evaluation of the siblings of an index case of congenital syphilis may be warranted if such an evaluation did not occur previously [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H18050031"><span class="h2">Diagnostic tests</span><span class="headingEndMark"> — </span>The diagnosis of syphilis is challenging because <em>T. pallidum</em> cannot be cultured in the laboratory. The diagnosis of syphilis may be established by:</p><p class="bulletIndent1"><span class="glyph">●</span>Demonstration of serologic reactions typical of syphilis (see <a class="local">'Interpretation'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detection of <em>T. pallidum</em> in infected body fluids, skin lesions, placenta, or umbilical cord by any of the following (see <a class="local">'Other tests'</a> below):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Direct visualization on darkfield microscopy  (<a class="graphic graphic_picture graphicRef72322" href="/d/graphic/72322.html" rel="external">picture 12</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>DFA, or </p><p class="bulletIndent2"><span class="glyph">•</span>PCR </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Demonstration of the <em>T. pallidum</em> by special stains  (<a class="graphic graphic_picture graphicRef50246" href="/d/graphic/50246.html" rel="external">picture 13</a>) or histopathologic examination [<a href="#rid67">67,68</a>]</p><p></p><p>Other tests that involve animal inoculation (eg, rabbit infectivity test [RIT]) are used mostly in research settings.</p><p>These testing methods are briefly summarized here and are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing", section on 'Diagnostic tests'</a>.)</p><p class="headingAnchor" id="H1141303133"><span class="h3">Serologic tests</span><span class="headingEndMark"> — </span>Serologic tests include: </p><p class="bulletIndent1"><span class="glyph">●</span>Nontreponemal tests – These include VDRL and RPR. (See <a class="local">'Nontreponemal tests'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treponemal tests – These include EIA and CIA, which are the two tests used for maternal reverse sequencing, as discussed above (see <a class="local">'Evaluation and diagnosis'</a> above). Other treponemal tests include fluorescent treponemal antibody absorption (FTA-ABS), <em>T. pallidum</em> particle agglutination (TP-PA), and microhemagglutination test for <em>T. pallidum</em> (MHA-TP). (See <a class="local">'Treponemal tests'</a> below.)</p><p></p><p class="headingAnchor" id="H4227692625"><span class="h4">Nontreponemal tests</span><span class="headingEndMark"> — </span>Nontreponemal tests are inexpensive and rapidly performed. They are sensitive, but not specific. Nontreponemal tests generally are used in the evaluation of neonates with possible congenital syphilis because they provide semiquantitative results, which can be compared with simultaneously obtained maternal results to categorize the likelihood of neonatal infection  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a>) [<a href="#rid54">54</a>]. Interpretation of the results is discussed below. (See <a class="local">'Interpretation'</a> below.)</p><p>Positive nontreponemal tests are reported as a titer of antibody (eg, 1:32, which represents the detection of antibody in serum diluted 32-fold). The neonate's titer usually is one to two dilutions less than mother's [<a href="#rid69">69</a>]. When the mother's titer is low, the neonate may have nonreactive serology but remains at risk for congenital syphilis. If testing is performed early after maternal infection, both the mother and newborn may have negative nontreponemal tests [<a href="#rid70">70</a>]. (See <a class="local">'Congenital syphilis less likely'</a> below.)</p><p>When congenital syphilis is suspected and the nontreponemal test is negative, evaluation for prozone phenomenon (excess antibody) evaluation should be requested (test at dilution 1:512 and if that dilution is negative, test at 1:1024 dilution). </p><p>Nontreponemal titers are also useful for monitoring during treatment since successful treatment is associated with a decline in the titer. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on 'Follow-up serology'</a>.) </p><p>A disadvantage of serologic tests for syphilis is that they detect immunoglobulin G [IgG] antibodies and do not differentiate between passively acquired maternal antibody and endogenous antibody produced by the fetus/neonate. Thus, it is necessary to compare the infant's titer with the mother's to determine the likelihood of congenital infection. It would be more desirable if testing detected only immunoglobulin M [IgM] antibodies, which do not cross the placenta, since this theoretically would be more accurate in confirming congenital infection. Unfortunately, a sufficiently sensitive and specific IgM assay is not available for routine use in the assessment of congenital syphilis [<a href="#rid53">53</a>]. The fluorescent antitreponemal IgM antibody test (IgM FTA-ABS) was used in the past, but because of lack of sensitivity, the CDC suspended its use for diagnostic testing of infants [<a href="#rid71">71,72</a>]. </p><p>For maternal testing during pregnancy, rapid point-of-care serologic tests are available that can be used as an alternative to laboratory testing, particularly in resource-limited settings. These tests do not require the laboratory infrastructure necessary for conventional tests and can be performed on finger-stick blood samples. They are easy to perform, it is easy to interpret their results, and they have a quick turnaround time (approximately 20 minutes). They have good sensitivity and specificity, comparable to those of conventional treponemal and nontreponemal tests [<a href="#rid73">73,74</a>]. However, they do not provide quantitative results and therefore are <strong>not </strong>appropriate for testing the neonate. Rapid serologic tests are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing", section on 'Rapid serologic tests'</a>.) </p><p class="headingAnchor" id="H1275674761"><span class="h4">Treponemal tests</span><span class="headingEndMark"> — </span>Treponemal tests (eg, FTA-ABS, TP-PA, EIA, CIA, MHA-TP) are <strong>not </strong>used in the evaluation of newborns with suspected congenital syphilis when maternal treponemal test results are available.</p><p>However, in instances when the diagnosis is uncertain, treponemal tests can be used later in infancy or childhood to help establish the diagnosis of congenital syphilis. In infants known to have had reactive nontreponemal serologic tests for syphilis as newborns or born to mothers who were seroreactive at delivery, a treponemal test can be performed after 12 to 15 months of age [<a href="#rid23">23,63</a>]. If the treponemal test is reactive, it should be repeated at 18 and 24 months of age. A positive treponemal test at ≥18 months of age (after the disappearance of passively acquired maternal antibody) confirms the diagnosis of congenital syphilis [<a href="#rid63">63,75</a>]. Children who have a positive treponemal test for syphilis at ≥18 months of age and did not previously receive treatment should undergo full evaluation and treatment. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on 'Penicillin therapy'</a>.)</p><p>Treponemal tests are discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing", section on 'Treponemal tests'</a>.)</p><p class="headingAnchor" id="H3163726470"><span class="h3">Other tests</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Darkfield microscopy and DFA</strong> – Darkfield microscopy and DFA testing can be used to detect the organism  (<a class="graphic graphic_picture graphicRef72322" href="/d/graphic/72322.html" rel="external">picture 12</a>); however, these tests are not routinely available in many clinical settings because they require special equipment to perform and considerable experience and expertise to properly interpret the results. Thus, for most clinicians, these tests are now viewed as alternative diagnostic tools.</p><p></p><p class="bulletIndent1">Where available, darkfield microscopy can be performed on body fluids (eg, nasal discharge) or moist skin lesions [<a href="#rid76">76</a>]. Darkfield microscopy enables demonstration of thin, delicate, corkscrew-shaped organisms with rigid, tightly wound spirals  (<a class="graphic graphic_picture graphicRef72322" href="/d/graphic/72322.html" rel="external">picture 12</a>). A positive darkfield slide illustrates the characteristic motility associated wi<em>th T. pallidum</em>: a forward and backward motion with rotation about the longitudinal axis [<a href="#rid76">76</a>]. Soft side-to-side bending and twisting may also be seen. Failure to identify spirochetes with darkfield microscopy does not exclude the diagnosis of syphilis. Darkfield microscopy depends upon the direct visualization of live, active spirochetes, characteristics that are rapidly destroyed by the previous use of antibiotics.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PCR</strong> – PCR has been used on neonatal blood and CSF for diagnosis of congenital syphilis, but these tests are not widely available [<a href="#rid18">18,40,41,77,78</a>]. Compared with isolation of the spirochetes by rabbit infectivity testing, the sensitivity and specificity of PCR on cerebrospinal fluid was 65 to 71 percent and 97 to 100 percent, respectively [<a href="#rid40">40,41</a>]. Among 17 infants who had spirochetes detected in CSF by rabbit inoculation, blood PCR was the best predictor of central nervous system infection with <em>T. pallidum</em> [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rabbit infectivity test</strong> – The RIT, which involves the inoculation of CSF or other body fluids into rabbits to determine the presence of viable <em>T. pallidum</em>, is the reference standard test for congenital syphilis [<a href="#rid23">23,26,56</a>]. However, routine use of RIT is not practical because it involves animal testing and is not widely available.</p><p></p><p class="headingAnchor" id="H30078895"><span class="h2">Interpretation</span><span class="headingEndMark"> — </span>To maximize treatment of newborns potentially infected with <em>T. pallidum</em>, the AAP categorizes congenital syphilis infection as "proven or highly probable," "possible," "less likely," and "unlikely"  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a>). The categories of "possible" and "less likely" include infants with normal physical examination and serological results not meeting diagnostic criteria but who nevertheless are still at risk of congenital syphilis. The inclusion of these at-risk infants helps to ensure that all possible cases are treated; however, not all at-risk infants are truly infected [<a href="#rid53">53</a>].</p><p>The following factors are considered when determining the likelihood of congenital infection:</p><p class="bulletIndent1"><span class="glyph">●</span>Whether the neonate has clinical findings that are consistent with congenital syphilis. (See <a class="local">'Early congenital syphilis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The neonate's syphilis serology, which must be compared with maternal titers. A titer that is ≥4-fold (two dilutions) higher than the maternal titer is indicative of infection (for example, a neonatal titer ≥1:32 when the maternal titer is 1:8). Lower titers in the newborn do not exclude congenital syphilis. (See <a class="local">'Nontreponemal tests'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mother's syphilis serology (in relation to previous tests and/or treatment and in relation to the neonate's titers).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maternal treatment for syphilis, including:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Whether the mother received treatment.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The timing of completion of treatment (before or during pregnancy; more or less than four weeks before delivery).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Whether treatment was adequate  (<a class="graphic graphic_table graphicRef73418" href="/d/graphic/73418.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The likelihood of failure of maternal therapy to prevent congenital disease – Higher maternal titers and unknown duration of maternal syphilis are associated with increased risk of treatment failure [<a href="#rid79">79</a>]. </p><p></p><p class="headingAnchor" id="H30078903"><span class="h3">Proven or highly probable congenital syphilis</span><span class="headingEndMark"> — </span>For newborns born to women who tested positive for syphilis during pregnancy, the diagnosis of congenital syphilis is proven or highly probable if the neonate has <strong>any</strong> of the following findings [<a href="#rid53">53</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Physical examination findings consistent with congenital syphilis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum VDRL or RPR titer that is ≥4-fold the corresponding maternal titer (which is equivalent to two dilutions [eg, neonate's titer ≥1:32 and maternal titer 1:8]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Positive darkfield microscopy  (<a class="graphic graphic_picture graphicRef72322" href="/d/graphic/72322.html" rel="external">picture 12</a>), DFA or PCR of lesions, body fluid(s), placenta, or umbilical cord (these tests are not be available in many clinical settings).</p><p></p><p>Neonates with proven or highly probable congenital syphilis should undergo further evaluation to assess the extent of organ involvement, as summarized in the table  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a>) and discussed below. (See <a class="local">'Evaluation for extent of organ involvement'</a> below.)</p><p>Regardless of the results of additional evaluation, neonates in this category should receive a 10-day course of IV penicillin, as summarized in the table and figure  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a> and <a class="graphic graphic_algorithm graphicRef140138" href="/d/graphic/140138.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on '10-day regimen'</a>.)</p><p class="headingAnchor" id="H87091566"><span class="h3">Possible congenital syphilis</span><span class="headingEndMark"> — </span>Neonates who meet <strong>all</strong> of the following criteria are considered to have possible congenital syphilis [<a href="#rid53">53,54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Mother was diagnosed with syphilis during pregnancy (reactive nontreponemal and treponemal tests) </p><p class="bulletIndent1"><span class="glyph">●</span>Mother was not treated, received inadequate/suboptimal therapy, or had evidence of relapse or reinfection  (<a class="graphic graphic_table graphicRef73418" href="/d/graphic/73418.html" rel="external">table 1</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Infant physical examination is normal</p><p class="bulletIndent1"><span class="glyph">●</span>Infant serum VDRL or RPR titer &lt;4-fold maternal titer</p><p></p><p>Some experts would also consider a newborn to have possible congenital syphilis if the mother had sexual contact with a person with primary or secondary syphilis within 90 days before delivery and was not treated or was inadequately treated, even if the mother had nonreactive serology [<a href="#rid25">25,80</a>].</p><p>For neonates in the "possible" congenital syphilis category, the need for additional evaluation and choice of treatment regimen are as follows  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a> and <a class="graphic graphic_algorithm graphicRef140138" href="/d/graphic/140138.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neonates at higher risk</strong> – For neonates in the "possible" category who have a higher risk of infection (ie, maternal risk of untreated syphilis is high <strong>or</strong> neonate's nontreponemal titer is reactive), we suggest performing further evaluation to assess the extent of organ involvement, as summarized in the table  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a>) and discussed below. (See <a class="local">'Evaluation for extent of organ involvement'</a> below.)</p><p></p><p class="bulletIndent1">If any part of the additional evaluation is abnormal, not performed, or uninterpretable (eg, traumatic lumbar puncture) or if follow-up is uncertain, the neonate should receive a 10-day course of IV penicillin, as summarized in the table and figure  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a> and <a class="graphic graphic_algorithm graphicRef140138" href="/d/graphic/140138.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on '10-day regimen'</a>.)</p><p></p><p class="bulletIndent1">If the additional evaluation is performed and is completely normal and if follow-up is assured, the neonate is treated with a single dose of long-acting intramuscular (IM) penicillin (ie, <a class="drug drug_pediatric" data-topicid="12686" href="/d/drug information/12686.html" rel="external">penicillin G benzathine</a>). (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on 'Single-dose regimen'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neonates at lower risk </strong>– For neonates in the "possible" category who have a lower risk of infection (ie, maternal risk of untreated syphilis is low <strong>and </strong>neonate's nontreponemal titer is nonreactive), no additional evaluation is required, and the neonate can be treated with a single dose of IM <a class="drug drug_pediatric" data-topicid="12686" href="/d/drug information/12686.html" rel="external">penicillin G benzathine</a>. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on 'Single-dose regimen'</a>.)</p><p></p><p>The CDC and AAP guidelines include a caveat that additional evaluation may not be necessary for neonates in the "possible" category if a 10-day treatment course is planned [<a href="#rid53">53,54</a>]. Nevertheless, we suggest performing the evaluation in higher-risk neonates (as defined above) since the evaluation may inform decisions regarding treatment and follow-up. </p><p class="headingAnchor" id="H20624891"><span class="h3">Congenital syphilis less likely</span><span class="headingEndMark"> — </span>Infection is less likely if <strong>all</strong> of the following criteria are met [<a href="#rid53">53,54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Mother was diagnosed with syphilis during pregnancy (reactive nontreponemal and treponemal tests)</p><p class="bulletIndent1"><span class="glyph">●</span>Mother completed appropriate treatment ≥4 weeks before delivery</p><p class="bulletIndent1"><span class="glyph">●</span>Mother has no evidence of reinfection or relapse </p><p class="bulletIndent1"><span class="glyph">●</span>Newborn's physical examination is normal</p><p class="bulletIndent1"><span class="glyph">●</span>Newborn's serum VDRL or RPR titers are &lt;4-fold the maternal titer</p><p></p><p>Neonates who meet these criteria do not require additional evaluation [<a href="#rid53">53,54</a>]. However, these neonates are at risk and should receive treatment with a single dose of IM <a class="drug drug_pediatric" data-topicid="12686" href="/d/drug information/12686.html" rel="external">penicillin G benzathine</a>, as summarized in the table and algorithm  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a> and <a class="graphic graphic_algorithm graphicRef140138" href="/d/graphic/140138.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on 'Single-dose regimen'</a>.)</p><p class="headingAnchor" id="H1132748072"><span class="h3">Congenital syphilis unlikely</span><span class="headingEndMark"> — </span>The diagnosis of congenital syphilis is unlikely if <strong>all </strong>of the following criteria are met [<a href="#rid53">53,54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Mother had reactive nontreponemal and treponemal tests</p><p class="bulletIndent1"><span class="glyph">●</span>Mother completed appropriate treatment before pregnancy</p><p class="bulletIndent1"><span class="glyph">●</span>Mother's nontreponemal titers remained low (VDRL &lt;1:2; RPR &lt;1:4) and stable before and during pregnancy and at delivery (ie, serofast)</p><p class="bulletIndent1"><span class="glyph">●</span>Newborn's physical examination is normal</p><p class="bulletIndent1"><span class="glyph">●</span>Newborn's serum VDRL or RPR titers are &lt;4-fold the maternal titer</p><p></p><p>These newborns generally do not require any additional evaluation or treatment (except in instances when follow-up cannot be assured, in which case a single dose of IM <a class="drug drug_pediatric" data-topicid="12686" href="/d/drug information/12686.html" rel="external">benzathine penicillin</a> is sufficient). (See  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome", section on 'Treatment according to diagnostic category'</a>.) </p><p class="headingAnchor" id="H30079950"><span class="h3">Congenital versus acquired syphilis</span><span class="headingEndMark"> — </span>In children who are found to have reactive serologic tests for syphilis after infancy, the distinction between congenital and acquired syphilis can be difficult [<a href="#rid1">1</a>]. The ultimate diagnosis may rest upon maternal history and clinical judgment [<a href="#rid1">1</a>]. Radiographic abnormalities of the long bones are more suggestive of congenital than acquired syphilis. (See <a class="local">'Radiographic abnormalities'</a> above.)</p><p>In a young child with reactive serologic tests for syphilis, the possibility of sexual abuse should be considered. (See  <a class="medical medical_review" href="/d/html/6605.html" rel="external">"Evaluation of sexual abuse in children and adolescents", section on 'Sexually transmitted infections'</a>.)</p><p class="headingAnchor" id="H4267397410"><span class="h1">CASE DEFINITION</span><span class="headingEndMark"> — </span>The Centers for Disease Control and Prevention (CDC) case definition for congenital syphilis is provided in the table  (<a class="graphic graphic_table graphicRef60607" href="/d/graphic/60607.html" rel="external">table 6</a>) [<a href="#rid1">1</a>]. Other case definitions may differ slightly from the CDC definition [<a href="#rid81">81</a>]. </p><p>In general, case definitions for congenital syphilis require only one of two criteria:</p><p class="bulletIndent1"><span class="glyph">●</span>The infant or child has physical, laboratory, or radiographic signs of congenital syphilis (confirmed/highly probable congenital syphilis), <strong>or</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The infant or child was born to a mother with untreated, inadequately, or suboptimally treated syphilis (presumed congenital syphilis)  (<a class="graphic graphic_table graphicRef73418" href="/d/graphic/73418.html" rel="external">table 1</a>)</p><p></p><p class="headingAnchor" id="H1364017073"><span class="h1">EVALUATION FOR EXTENT OF ORGAN INVOLVEMENT</span><span class="headingEndMark"> — </span>For neonates in the "proven or highly probably" category and those in the "possible" category who have a higher risk of infection (ie, high risk of maternal untreated syphilis or neonate's nontreponemal titer is reactive), we suggest performing <strong>all</strong> of the following additional tests to evaluate for the extent of organ involvement  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a>) [<a href="#rid53">53,54</a>]. Details about these tests are provided in the sections below. </p><p class="bulletIndent1"><span class="glyph">●</span>Lumbar puncture (LP) for cerebrospinal fluid (CSF) analysis. (See <a class="local">'Lumbar puncture'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count (CBC) with differential and platelet count. (See <a class="local">'Blood tests'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Liver function tests (LFTs, including serum bilirubin and liver enzymes); if LFTs are grossly abnormal, coagulation tests should also be obtained. (See <a class="local">'Blood tests'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skeletal survey. (See <a class="local">'Skeletal survey'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hearing evaluation and ophthalmologic examination – Our practice is to routinely perform these evaluations in all newborns who are undergoing evaluation for extent of organ involvement. This practice differs from the Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics (AAP) guidelines, which do not recommend routinely performing these assessments since retinitis and hearing loss are rare in newborns with early congenital syphilis [<a href="#rid53">53,54</a>]. However, in affected infants, hearing and vision problems may not be clinically apparent until later in childhood, and there can be serious developmental consequences if these problems are not diagnosed and treated in a timely manner. Thus, we suggest routinely performing these assessments in the neonatal period. (See <a class="local">'Hearing evaluation'</a> below and <a class="local">'Eye examination'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other tests as clinically indicated (eg, neuroimaging if there are concerning neurologic findings, chest radiograph if there are pulmonary findings). (See <a class="local">'Other assessments'</a> below.)</p><p></p><p>The CDC and AAP guidelines include a caveat that the above evaluation is not necessary for neonates in the "possible" category who will be treated with a 10-day course of parenteral penicillin [<a href="#rid53">53,54</a>]. Nevertheless, we suggest performing the evaluation in neonates in this category who are at higher risk for infection (as defined above) since the evaluation may inform treatment and follow-up decisions. (See <a class="local">'Possible congenital syphilis'</a> above.)</p><p>No additional evaluation is necessary for neonates in the "possible" category who have a lower risk of infection (ie, low risk of maternal untreated syphilis <strong>and</strong> neonate's nontreponemal titer is nonreactive) and those in the "less likely" and "unlikely" categories. </p><p class="headingAnchor" id="H2971083923"><span class="h2">Lumbar puncture</span><span class="headingEndMark"> — </span>If LP is performed, CSF analysis should include [<a href="#rid53">53,54</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Cell count with differential</p><p class="bulletIndent1"><span class="glyph">●</span>CSF protein and glucose</p><p class="bulletIndent1"><span class="glyph">●</span>CSF Venereal Disease Research Laboratory (VDRL)</p><p></p><p>Ideally, the LP is nontraumatic since results of traumatic taps are not interpretable in this setting.</p><p>CSF analysis may help to establish the diagnosis in some infants and it informs decisions about the need for long-term CSF follow-up [<a href="#rid42">42,45</a>]. However, the diagnosis of congenital central nervous system (CNS) syphilis can be difficult to establish. Given the lack of a widely available laboratory test with high sensitivity and specificity for CNS syphilis and the potential consequences of untreated CNS syphilis, the diagnosis of CNS syphilis usually is presumed in children with clinical, radiographic, and laboratory abnormalities compatible with congenital syphilis. (See  <a class="medical medical_review" href="/d/html/7599.html" rel="external">"Neurosyphilis"</a>.)</p><p class="headingAnchor" id="H3483948083"><span class="h2">Blood tests</span><span class="headingEndMark"> — </span>Routine blood tests performed in infants undergoing evaluation for congenital syphilis include:</p><p class="bulletIndent1"><span class="glyph">●</span>CBC with differential and platelet count to assess for anemia and other hematologic manifestations </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>LFTs, including serum bilirubin and liver enzymes, to assess for liver involvement, which is common in symptomatic newborns</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If LFTs are grossly abnormal, coagulation tests should also be obtained</p><p></p><p class="headingAnchor" id="H1502077381"><span class="h2">Skeletal survey</span><span class="headingEndMark"> — </span>Radiographic evaluation to detect bony abnormalities should be performed in all neonates who warrant evaluation for extent of organ involvement. The CDC and AAP guidelines suggest limiting the radiographic evaluation to the long bones (femur, tibia/fibular, humerus, and radius/ulna) since these are the sites most frequently involved [<a href="#rid53">53,54</a>]. However, we generally perform a full skeletal survey since bony abnormalities are occasionally noted in other locations (eg, ribs, clavicles, hands, and feet) [<a href="#rid82">82</a>].</p><p>A skeletal survey (or long-bone radiographs) can also be helpful if there is uncertainty as to whether the infant or child has congenital versus acquired syphilis. Bony abnormalities are suggestive of congenital infection, as discussed above. (See <a class="local">'Congenital versus acquired syphilis'</a> above.) </p><p>Radiographic abnormalities characteristically are bilateral, symmetric, and polyostotic  (<a class="graphic graphic_diagnosticimage graphicRef62990 graphicRef72752 graphicRef74323 graphicRef52714" href="/d/graphic/62990.html" rel="external">image 1A-D</a>); the femur, humerus, and tibia are most frequently involved, as described above. (See <a class="local">'Radiographic abnormalities'</a> above.)</p><p class="headingAnchor" id="H3772416699"><span class="h2">Hearing evaluation</span><span class="headingEndMark"> — </span>All infants and children with proven or highly probable congenital syphilis should undergo formal hearing assessment, typically with auditory brainstem response (ABR). This is best accomplished while the newborn is still in the hospital but can be done in the outpatient setting if follow-up is assured. (See  <a class="medical medical_review" href="/d/html/6297.html" rel="external">"Hearing loss in children: Screening and evaluation", section on 'Formal audiology'</a>.)</p><p>In many settings, all newborns routinely undergo hearing screening prior to discharge from the birth hospitalization. Otoacoustic emissions (OAE) screening is often used for this purpose. OAE is generally less sensitive compared with ABR (ie, higher false negative rate). Thus, in infants with congenital syphilis, formal audiologic evaluation with ABR is generally warranted even if the newborn passes the initial OAE screen. Newborns who pass a screening performed with automated ABR do not require formal audiology. (See  <a class="medical medical_review" href="/d/html/4985.html" rel="external">"Screening the newborn for hearing loss"</a>.)</p><p class="headingAnchor" id="H2944637519"><span class="h2">Eye examination</span><span class="headingEndMark"> — </span>All infants and children with proven or highly probable congenital syphilis should have formal vision assessment and dilated eye examination performed by a pediatric eye care specialist. This is best accomplished while the newborn is still in the hospital but can be done in the outpatient setting if follow-up is assured. (See  <a class="medical medical_review" href="/d/html/6261.html" rel="external">"Vision screening and assessment in infants and children"</a>.)</p><p class="headingAnchor" id="H1724789700"><span class="h2">Other assessments</span><span class="headingEndMark"> — </span>Additional testing is guided by the clinical findings and may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Neuroimaging if there are concerning neurologic findings</p><p class="bulletIndent1"><span class="glyph">●</span>Chest radiograph if there are pulmonary findings</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal imaging if there is significant organomegaly or other concerning findings</p><p></p><p class="headingAnchor" id="H3342328028"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis for congenital syphilis includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Other congenital and neonatal infections, including  (<a class="graphic graphic_table graphicRef76743" href="/d/graphic/76743.html" rel="external">table 7</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Toxoplasmosis infection (see  <a class="medical medical_review" href="/d/html/6756.html" rel="external">"Toxoplasmosis and pregnancy", section on 'Fetal infection'</a> and  <a class="medical medical_review" href="/d/html/14426.html" rel="external">"Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Clinical features'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rubella virus infection (see  <a class="medical medical_review" href="/d/html/6047.html" rel="external">"Congenital rubella", section on 'Evaluation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cytomegalovirus infection (see  <a class="medical medical_review" href="/d/html/14430.html" rel="external">"Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Clinical manifestations'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Herpes simplex virus infection (see  <a class="medical medical_review" href="/d/html/6037.html" rel="external">"Neonatal herpes simplex virus infection: Clinical features and diagnosis", section on 'Evaluation and diagnosis'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Congenital lymphocytic choriomeningitis virus infection (see  <a class="medical medical_review" href="/d/html/5980.html" rel="external">"Viral meningitis in children: Epidemiology, pathogenesis, and etiology", section on 'Lymphocytic choriomeningitis virus'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neonatal sepsis (see  <a class="medical medical_review" href="/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Evaluation and initial management'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other causes of neonatal jaundice, hepatomegaly, and cholestasis, which are summarized in the table  (<a class="graphic graphic_table graphicRef64995" href="/d/graphic/64995.html" rel="external">table 8</a>) and reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/5945.html" rel="external">"Causes of cholestasis in neonates and young infants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other causes of long-bone abnormalities (eg, osteomyelitis, rickets, physical abuse) or failure to move an extremity. (See  <a class="medical medical_review" href="/d/html/6614.html" rel="external">"Differential diagnosis of the orthopedic manifestations of child abuse"</a> and  <a class="medical medical_review" href="/d/html/5266.html" rel="external">"Brachial plexus syndromes", section on 'Neonatal brachial plexus palsy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other causes of vesicular lesions in neonates, which are summarized in the table  (<a class="graphic graphic_table graphicRef75417" href="/d/graphic/75417.html" rel="external">table 9</a>), and reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant"</a>.)</p><p></p><p>Historical features, associated findings, and/or laboratory testing usually differentiate these conditions from congenital syphilis.</p><p class="headingAnchor" id="H5447307"><span class="h1">REPORTING REQUIREMENTS</span><span class="headingEndMark"> — </span>In the United States, congenital syphilis is a national notifiable disease [<a href="#rid83">83</a>]. However, reporting requirements vary by state. Reporting to the Centers for Disease Control and Prevention by the states is voluntary. For reporting purposes, congenital syphilis includes stillbirths due to syphilis, cases of congenital syphilis detected in newborns, and cases of congenitally acquired syphilis in infants and children [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H1252625051"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_society_guidelines" href="/d/html/111578.html" rel="external">"Society guideline links: TORCH infections"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_society_guidelines" href="/d/html/111582.html" rel="external">"Society guideline links: Sexually transmitted infections"</a>.)</p><p></p><p class="headingAnchor" id="H180672643"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83398.html" rel="external">"Patient education: Congenital syphilis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H9144237"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission and epidemiology</strong> – Congenital syphilis is acquired through transplacental transmission of spirochetes. Pregnant individuals with untreated primary or secondary syphilis are at highest risk of transmitting syphilis to the fetus. <em>Treponema pallidum</em> is not transferred in breast milk. In the United States, reported cases of congenital syphilis have increased dramatically since 2012  (<a class="graphic graphic_figure graphicRef55877" href="/d/graphic/55877.html" rel="external">figure 1</a>). (See <a class="local">'Transmission'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Early congenital syphilis</strong> – Early congenital syphilis is arbitrarily defined by clinical manifestations with onset before two years of age. Manifestations of early congenital syphilis are varied and unpredictable, as summarized in the table  (<a class="graphic graphic_table graphicRef67809" href="/d/graphic/67809.html" rel="external">table 3</a>). (See <a class="local">'Early congenital syphilis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Late congenital syphilis</strong> – Late congenital syphilis is arbitrarily defined by clinical manifestations with onset after two years of age. Manifestations of late congenital syphilis are summarized in the table  (<a class="graphic graphic_table graphicRef81529" href="/d/graphic/81529.html" rel="external">table 4</a>); most are related to scarring or persistent inflammation from early infection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical suspicion</strong> – The diagnosis of congenital syphilis should be suspected in all infants born to mothers who have reactive nontreponemal and treponemal tests for syphilis during pregnancy and infants/children with clinical findings compatible with congenital syphilis  (<a class="graphic graphic_table graphicRef67809" href="/d/graphic/67809.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef81529" href="/d/graphic/81529.html" rel="external">table 4</a>). (See <a class="local">'Clinical suspicion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – The initial evaluation for congenital syphilis includes the following (see <a class="local">'Initial evaluation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Venereal Disease Research Laboratory (VDRL) or rapid plasma reagin (RPR) titer; titers should be measured in both the newborn and the mother using the same test. (See <a class="local">'Nontreponemal tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Physical examination for evidence of congenital syphilis  (<a class="graphic graphic_table graphicRef67809" href="/d/graphic/67809.html" rel="external">table 3</a>). (See <a class="local">'Clinical findings'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Where available, testing for <em>T. pallidum </em>can be performed with direct fluorescent antibody (DFA) staining, darkfield microscopy, and/or polymerase chain reaction (PCR) of nasal discharge and/or swabs of skin lesions; however, these tests are not available in many clinical settings. (See <a class="local">'Other tests'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If possible, pathologic examination of the placenta and umbilical cord with specific staining. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of congenital syphilis may be established by any of the following  (<a class="graphic graphic_table graphicRef60607" href="/d/graphic/60607.html" rel="external">table 6</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Demonstration of serologic reactions typical of syphilis in relation to mother's serology</p><p class="bulletIndent2"><span class="glyph">•</span>Detection of <em>T. pallidum</em> by darkfield microscopy  (<a class="graphic graphic_picture graphicRef72322" href="/d/graphic/72322.html" rel="external">picture 12</a>), DFA or PCR of infected body fluids or lesions, placenta, or umbilical cord</p><p class="bulletIndent2"><span class="glyph">•</span>Demonstration of the <em>T. pallidum</em> by special stains  (<a class="graphic graphic_picture graphicRef50246" href="/d/graphic/50246.html" rel="external">picture 13</a>) or histopathologic examination </p><p></p><p class="bulletIndent1">Based upon the physical examination, maternal and infant VDRL or RPR titers, maternal treatment history, and other findings, the likelihood of congenital syphilis can be categorized as "proven or highly probable," "possible," "less likely," and "unlikely"  (<a class="graphic graphic_algorithm graphicRef140138" href="/d/graphic/140138.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a>). (See <a class="local">'Interpretation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Further evaluation</strong> – For neonates in the "proven or highly probably" category and those in the "possible" category who have a higher risk of infection (ie, high risk of maternal untreated syphilis or neonate's nontreponemal titer is reactive), we suggest performing <strong>all</strong> of the following additional tests to evaluate for the extent of organ involvement  (<a class="graphic graphic_table graphicRef140142" href="/d/graphic/140142.html" rel="external">table 5</a>) (see <a class="local">'Evaluation for extent of organ involvement'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lumbar puncture for cerebrospinal fluid (CSF) analysis (see <a class="local">'Lumbar puncture'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Complete blood count (CBC) with differential and platelet count (see <a class="local">'Blood tests'</a> above) </p><p class="bulletIndent2"><span class="glyph">•</span>Liver function tests (LFTs) (see <a class="local">'Blood tests'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Skeletal survey (see <a class="local">'Skeletal survey'</a> above) </p><p class="bulletIndent2"><span class="glyph">•</span>Hearing evaluation and ophthalmologic examination (see <a class="local">'Hearing evaluation'</a> above and <a class="local">'Eye examination'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Other tests as clinically indicated (eg, neuroimaging if there are concerning neurologic findings, chest radiograph if there are pulmonary findings) (see <a class="local">'Other assessments'</a> above)</p><p></p><p class="bulletIndent1">No additional evaluation is necessary for neonates in the "possible" category who have a lower risk of infection (ie, low risk of maternal untreated syphilis <strong>and</strong> neonate's nontreponemal titer is nonreactive) and those in the "less likely" and "unlikely" categories. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of congenital syphilis includes other congenital infections  (<a class="graphic graphic_table graphicRef76743" href="/d/graphic/76743.html" rel="external">table 7</a>); neonatal sepsis; and other causes of neonatal hepatitis, hydrops fetalis, long-bone abnormalities, and cutaneous lesions. Historical features, associated clinical findings, and/or laboratory testing usually differentiate these conditions from congenital syphilis. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H3538840227"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate would like to acknowledge Simon R Dobson, MD, FRCP(C), who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Centers for Disease Control and Prevention. Syphilis (Treponema pallidum) 2018 Case Definition. https://ndc.services.cdc.gov/case-definitions/syphilis-2018/ (Accessed on June 17, 2021).</li><li><a class="nounderline abstract_t">Walker DG, Walker GJ. Prevention of congenital syphilis--time for action. Bull World Health Organ 2004; 82:401.</a></li><li><a class="nounderline abstract_t">Korenromp EL, Rowley J, Alonso M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012. PLoS One 2019; 14:e0211720.</a></li><li class="breakAll">Sexually transmitted disease surveillance, 2015. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/std/stats15/std-surveillance-2015-print.pdf (Accessed on October 25, 2016).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Congenital syphilis - United States, 2003-2008. MMWR Morb Mortal Wkly Rep 2010; 59:413.</a></li><li><a class="nounderline abstract_t">Caddy SC, Lee BE, Sutherland K, et al. Pregnancy and neonatal outcomes of women with reactive syphilis serology in Alberta, 2002 to 2006. J Obstet Gynaecol Can 2011; 33:453.</a></li><li><a class="nounderline abstract_t">Lago EG, Vaccari A, Fiori RM. Clinical features and follow-up of congenital syphilis. Sex Transm Dis 2013; 40:85.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Congenital syphilis--United States, 1998. MMWR Morb Mortal Wkly Rep 1999; 48:757.</a></li><li><a class="nounderline abstract_t">Bowen V, Su J, Torrone E, et al. Increase in incidence of congenital syphilis - United States, 2012-2014. MMWR Morb Mortal Wkly Rep 2015; 64:1241.</a></li><li><a class="nounderline abstract_t">Kimball A, Torrone E, Miele K, et al. Missed Opportunities for Prevention of Congenital Syphilis - United States, 2018. MMWR Morb Mortal Wkly Rep 2020; 69:661.</a></li><li class="breakAll">Centers for Disease Control and Prevention. National Overview - Sexually Transmitted Disease Surveillance, 2019: Syphilis. Available at: https://www.cdc.gov/std/statistics/2019/overview.htm#Syphilis (Accessed on April 25, 2021).</li><li class="breakAll">Centers for Disease Control and Prevention (CDC) Sexually Transmitted Disease Surveillance, 2020, available at: https://www.cdc.gov/std/statistics/2020/tables.htm (Accessed on October 06, 2022).</li><li><a class="nounderline abstract_t">DiOrio D, Kroeger K, Ross A. Social Vulnerability in Congenital Syphilis Case Mothers: Qualitative Assessment of Cases in Indiana, 2014 to 2016. Sex Transm Dis 2018; 45:447.</a></li><li><a class="nounderline abstract_t">Neblett Fanfair R, Tao G, Owusu-Edusei K, et al. Suboptimal Prenatal Syphilis Testing Among Commercially Insured Women in the United States, 2013. Sex Transm Dis 2017; 44:219.</a></li><li><a class="nounderline abstract_t">Slutsker JS, Hennessy RR, Schillinger JA. Factors Contributing to Congenital Syphilis Cases — New York City, 2010–2016. MMWR Morb Mortal Wkly Rep 2018; :1088.</a></li><li><a class="nounderline abstract_t">Matthias JM, Rahman MM, Newman DR, Peterman TA. Effectiveness of Prenatal Screening and Treatment to Prevent Congenital Syphilis, Louisiana and Florida, 2013-2014. Sex Transm Dis 2017; 44:498.</a></li><li><a class="nounderline abstract_t">Woods CR. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis 2005; 16:245.</a></li><li><a class="nounderline abstract_t">Grimprel E, Sanchez PJ, Wendel GD, et al. Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol 1991; 29:1711.</a></li><li><a class="nounderline abstract_t">Nathan L, Twickler DM, Peters MT, et al. Fetal syphilis: correlation of sonographic findings and rabbit infectivity testing of amniotic fluid. J Ultrasound Med 1993; 12:97.</a></li><li><a class="nounderline abstract_t">Qureshi F, Jacques SM, Reyes MP. Placental histopathology in syphilis. Hum Pathol 1993; 24:779.</a></li><li><a class="nounderline abstract_t">FIUMARA NJ, FLEMING WL, DOWNING JG, GOOD FL. The incidence of prenatal syphilis at the Boston City Hospital. N Engl J Med 1952; 247:48.</a></li><li><a class="nounderline abstract_t">INGRAHAM NR Jr. The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol Suppl (Stockh) 1950; 31:60.</a></li><li class="breakAll">Kollmann TR, Dobson SR. Syphilis. In: Infectious Diseases of the Fetus and Newborn Infant, 8th ed, Wilson CB, Nizet V, Maldonado Y, Remington JS, Klein JO, (Eds), Elsevier Saunders, Philidelphia, PA 2016. p.512.</li><li><a class="nounderline abstract_t">Christian CW, Lavelle J, Bell LM. Preschoolers with syphilis. Pediatrics 1999; 103:E4.</a></li><li class="breakAll">Dobson SR, Sanchez PJ. Syphilis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier Saunders, Philadelphia 2019. p.1268.</li><li><a class="nounderline abstract_t">Herremans T, Kortbeek L, Notermans DW. A review of diagnostic tests for congenital syphilis in newborns. Eur J Clin Microbiol Infect Dis 2010; 29:495.</a></li><li><a class="nounderline abstract_t">Ortiz-Lopez N, Diez M, Diaz O, et al. Epidemiological surveillance of congenital syphilis in Spain, 2000-2010. Pediatr Infect Dis J 2012; 31:988.</a></li><li class="breakAll">Rawstron SA, Hawkes SJ. Treponema pallidum (Syphilis). In: Principles and Practice of Pediatric Infectious Diseases, 4th, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, Edinburgh 2012. p.941.</li><li><a class="nounderline abstract_t">Rathbun KC. Congenital syphilis. Sex Transm Dis 1983; 10:93.</a></li><li><a class="nounderline abstract_t">Ricci JM, Fojaco RM, O'Sullivan MJ. Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986-1988. Obstet Gynecol 1989; 74:687.</a></li><li><a class="nounderline abstract_t">Fojaco RM, Hensley GT, Moskowitz L. Congenital syphilis and necrotizing funisitis. JAMA 1989; 261:1788.</a></li><li><a class="nounderline abstract_t">Sheffield JS, Sánchez PJ, Wendel GD Jr, et al. Placental histopathology of congenital syphilis. Obstet Gynecol 2002; 100:126.</a></li><li><a class="nounderline abstract_t">Hollier LM, Harstad TW, Sanchez PJ, et al. Fetal syphilis: clinical and laboratory characteristics. Obstet Gynecol 2001; 97:947.</a></li><li><a class="nounderline abstract_t">Braunstein GD, Lewis EJ, Galvanek EG, et al. The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med 1970; 48:643.</a></li><li><a class="nounderline abstract_t">Gamble CN, Reardan JB. Immunopathogenesis of syphilitic glomerulonephritis. Elution of antitreponemal antibody from glomerular immune-complex deposits. N Engl J Med 1975; 292:449.</a></li><li><a class="nounderline abstract_t">Kaplan BS, Wiglesworth FW, Marks MI, Drummond KN. The glomerulopathy of congenital syphilis--an immune deposit disease. J Pediatr 1972; 81:1154.</a></li><li><a class="nounderline abstract_t">Dobson SR, Taber LH, Baughn RE. Characterization of the components in circulating immune complexes from infants with congenital syphilis. J Infect Dis 1988; 158:940.</a></li><li><a class="nounderline abstract_t">Radcliffe M, Meyer M, Roditi D, Malan A. Single-dose benzathine penicillin in infants at risk of congenital syphilis--results of a randomised study. S Afr Med J 1997; 87:62.</a></li><li><a class="nounderline abstract_t">Paryani SG, Vaughn AJ, Crosby M, Lawrence S. Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. J Pediatr 1994; 125:471.</a></li><li><a class="nounderline abstract_t">Michelow IC, Wendel GD Jr, Norgard MV, et al. Central nervous system infection in congenital syphilis. N Engl J Med 2002; 346:1792.</a></li><li><a class="nounderline abstract_t">Sánchez PJ, Wendel GD Jr, Grimprel E, et al. Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis 1993; 167:148.</a></li><li><a class="nounderline abstract_t">Beeram MR, Chopde N, Dawood Y, et al. Lumbar puncture in the evaluation of possible asymptomatic congenital syphilis in neonates. J Pediatr 1996; 128:125.</a></li><li><a class="nounderline abstract_t">Daaboul JJ, Kartchner W, Jones KL. Neonatal hypoglycemia caused by hypopituitarism in infants with congenital syphilis. J Pediatr 1993; 123:983.</a></li><li><a class="nounderline abstract_t">Nolt D, Saad R, Kouatli A, et al. Survival with hypopituitarism from congenital syphilis. Pediatrics 2002; 109:e63.</a></li><li><a class="nounderline abstract_t">Moyer VA, Schneider V, Yetman R, et al. Contribution of long-bone radiographs to the management of congenital syphilis in the newborn infant. Arch Pediatr Adolesc Med 1998; 152:353.</a></li><li><a class="nounderline abstract_t">Brion LP, Manuli M, Rai B, et al. Long-bone radiographic abnormalities as a sign of active congenital syphilis in asymptomatic newborns. Pediatrics 1991; 88:1037.</a></li><li><a class="nounderline abstract_t">Kocher MS, Caniza M. Parrot pseudoparalysis of the upper extremities. A case report. J Bone Joint Surg Am 1996; 78:284.</a></li><li class="breakAll">Case of the week. Newborn infant with hepatomegaly. VCU Health System. http://www.pedsradiology.com/Historyanswer.aspx?qid=144&amp;fid=1 (Accessed on August 12, 2011).</li><li><a class="nounderline abstract_t">Rasool MN, Govender S. The skeletal manifestations of congenital syphilis. A review of 197 cases. J Bone Joint Surg Br 1989; 71:752.</a></li><li><a class="nounderline abstract_t">Lascari AD, Diamond J, Nolan BE. Anemia as the only presenting manifestation of congenital syphilis. Clin Pediatr (Phila) 1976; 15:90.</a></li><li><a class="nounderline abstract_t">Bulova SI, Schwartz E, Harrer WV. Hydrops fetalis and congenital syphilis. Pediatrics 1972; 49:285.</a></li><li><a class="nounderline abstract_t">Shah MC, Barton LL. Congenital syphilitic hepatitis. Pediatr Infect Dis J 1989; 8:891.</a></li><li><a class="nounderline abstract_t">Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1.</a></li><li class="breakAll">American Academy of Pediatrics. Syphilis. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.729.</li><li><a class="nounderline abstract_t">Cooper JM, Sánchez PJ. Congenital syphilis. Semin Perinatol 2018; 42:176.</a></li><li><a class="nounderline abstract_t">Chakraborty R, Luck S. Syphilis is on the increase: the implications for child health. Arch Dis Child 2008; 93:105.</a></li><li><a class="nounderline abstract_t">PUTKONEN T. Does early treatment prevent dental changes in congenital syphilis? Acta Derm Venereol 1963; 43:240.</a></li><li><a class="nounderline abstract_t">Stamos JK, Rowley AH. Timely diagnosis of congenital infections. Pediatr Clin North Am 1994; 41:1017.</a></li><li><a class="nounderline abstract_t">OKSALA A. Interstitial keratitis after adequate penicillin therapy; a case report. Br J Vener Dis 1957; 33:113.</a></li><li><a class="nounderline abstract_t">Fiumara NJ, Lessell S. Manifestations of late congenital syphilis. An analysis of 271 patients. Arch Dermatol 1970; 102:78.</a></li><li><a class="nounderline abstract_t">Dorfman DH, Glaser JH. Congenital syphilis presenting in infants after the newborn period. N Engl J Med 1990; 323:1299.</a></li><li><a class="nounderline abstract_t">Adams DA, Kerr AG, Smyth GD, Cinnamond MJ. Congenital syphilitic deafness--a further review. J Laryngol Otol 1983; 97:399.</a></li><li class="breakAll">Dobson SR, Sanchez PJ. Syphilis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th Ed, Cherry JD, Harrison GJ, Kaplan SL, Steinbach, WJ, Hotez, PJ (Eds), Elsevier, Philadelphia, PA 2019. p.1268.</li><li class="breakAll">WHO guidelines for the treatment of Treponema pallidum (syphilis). 2016. Available at: http://apps.who.int/iris/bitstream/10665/249572/1/9789241549806-eng.pdf?ua=1 (Accessed on September 15, 2016).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2011; 60:133.</a></li><li><a class="nounderline abstract_t">Genest DR, Choi-Hong SR, Tate JE, et al. Diagnosis of congenital syphilis from placental examination: comparison of histopathology, Steiner stain, and polymerase chain reaction for Treponema pallidum DNA. Hum Pathol 1996; 27:366.</a></li><li><a class="nounderline abstract_t">Hardy JB, Hardy PH, Oppenheimer EH, et al. Failure of penicillin in a newborn with congenital syphilis. JAMA 1970; 212:1345.</a></li><li><a class="nounderline abstract_t">Rawstron SA, Vetrano J, Tannis G, Bromberg K. Congenital syphilis: detection of Treponema pallidum in stillborns. Clin Infect Dis 1997; 24:24.</a></li><li><a class="nounderline abstract_t">Rawstron SA, Bromberg K. Comparison of maternal and newborn serologic tests for syphilis. Am J Dis Child 1991; 145:1383.</a></li><li><a class="nounderline abstract_t">Binnicker MJ, Jespersen DJ, Rollins LO. Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays. J Clin Microbiol 2011; 49:1313.</a></li><li><a class="nounderline abstract_t">Stoll BJ, Lee FK, Larsen S, et al. Clinical and serologic evaluation of neonates for congenital syphilis: a continuing diagnostic dilemma. J Infect Dis 1993; 167:1093.</a></li><li><a class="nounderline abstract_t">Lefevre JC, Bertrand MA, Bauriaud R. Evaluation of the Captia enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum in syphilis. J Clin Microbiol 1990; 28:1704.</a></li><li><a class="nounderline abstract_t">Lago EG. Current Perspectives on Prevention of Mother-to-Child Transmission of Syphilis. Cureus 2016; 8:e525.</a></li><li><a class="nounderline abstract_t">Bonawitz RE, Duncan J, Hammond E, et al. Assessment of the impact of rapid syphilis tests on syphilis screening and treatment of pregnant women in Zambia. Int J Gynaecol Obstet 2015; 130 Suppl 1:S58.</a></li><li><a class="nounderline abstract_t">Rawstron SA, Mehta S, Marcellino L, et al. Congenital syphilis and fluorescent treponemal antibody test reactivity after the age of 1 year. Sex Transm Dis 2001; 28:412.</a></li><li><a class="nounderline abstract_t">Larsen SA. Syphilis. Clin Lab Med 1989; 9:545.</a></li><li><a class="nounderline abstract_t">Woznicová V, Smajs D, Wechsler D, et al. Detection of Treponema pallidum subsp. pallidum from skin lesions, serum, and cerebrospinal fluid in an infant with congenital syphilis after clindamycin treatment of the mother during pregnancy. J Clin Microbiol 2007; 45:659.</a></li><li><a class="nounderline abstract_t">Garel B, Grange P, Benhaddou N, et al. Congenital syphilis: A prospective study of 22 cases diagnosed by PCR. Ann Dermatol Venereol 2019; 146:696.</a></li><li><a class="nounderline abstract_t">McFarlin BL, Bottoms SF, Dock BS, Isada NB. Epidemic syphilis: maternal factors associated with congenital infection. Am J Obstet Gynecol 1994; 170:535.</a></li><li><a class="nounderline abstract_t">Zenker PN, Berman SM. Congenital syphilis: trends and recommendations for evaluation and management. Pediatr Infect Dis J 1991; 10:516.</a></li><li><a class="nounderline abstract_t">Risser WL, Hwang LY. Problems in the current case definitions of congenital syphilis. J Pediatr 1996; 129:499.</a></li><li><a class="nounderline abstract_t">Sachdev M, Bery K, Chawla S. Osseous manifestations in congenital syphilis: a study of 55 cases. Clin Radiol 1982; 33:319.</a></li><li class="breakAll">Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System. http://www.cdc.gov/osels/ph_surveillance/nndss/phs/infdis.htm (Accessed on August 12, 2011).</li></ol></div><div id="topicVersionRevision">Topic 14428 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://ndc.services.cdc.gov/case-definitions/syphilis-2018/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Centers for Disease Control and Prevention. Syphilis (Treponema pallidum) 2018 Case Definition. https://ndc.services.cdc.gov/case-definitions/syphilis-2018/ (Accessed on June 17, 2021).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15356930" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevention of congenital syphilis--time for action.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30811406" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30811406" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20395934" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Congenital syphilis - United States, 2003-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21639965" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pregnancy and neonatal outcomes of women with reactive syphilis serology in Alberta, 2002 to 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23324972" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical features and follow-up of congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10499788" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Congenital syphilis--United States, 1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26562206" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Increase in incidence of congenital syphilis - United States, 2012-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32497029" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Missed Opportunities for Prevention of Congenital Syphilis - United States, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32497029" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Missed Opportunities for Prevention of Congenital Syphilis - United States, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32497029" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Missed Opportunities for Prevention of Congenital Syphilis - United States, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29465662" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Social Vulnerability in Congenital Syphilis Case Mothers: Qualitative Assessment of Cases in Indiana, 2014 to 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28282647" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Suboptimal Prenatal Syphilis Testing Among Commercially Insured Women in the United States, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Factors Contributing to Congenital Syphilis Cases—New York City, 2010–2016</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28703731" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effectiveness of Prenatal Screening and Treatment to Prevent Congenital Syphilis, Louisiana and Florida, 2013-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210105" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Syphilis in children: congenital and acquired.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1761693" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8468743" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Fetal syphilis: correlation of sonographic findings and rabbit infectivity testing of amniotic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8319956" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Placental histopathology in syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14941281" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The incidence of prenatal syphilis at the Boston City Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14829195" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The value of penicillin alone in the prevention and treatment of congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14829195" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The value of penicillin alone in the prevention and treatment of congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9917484" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Preschoolers with syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9917484" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Preschoolers with syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20336337" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A review of diagnostic tests for congenital syphilis in newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22572752" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Epidemiological surveillance of congenital syphilis in Spain, 2000-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22572752" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Epidemiological surveillance of congenital syphilis in Spain, 2000-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6318372" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2812644" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986-1988.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2918676" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Congenital syphilis and necrotizing funisitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12100814" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Placental histopathology of congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11384701" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fetal syphilis: clinical and laboratory characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4912935" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The nephrotic syndrome associated with secondary syphilis. An immune deposit disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1089888" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Immunopathogenesis of syphilitic glomerulonephritis. Elution of antitreponemal antibody from glomerular immune-complex deposits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4566039" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The glomerulopathy of congenital syphilis--an immune deposit disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3053929" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Characterization of the components in circulating immune complexes from infants with congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9063317" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Single-dose benzathine penicillin in infants at risk of congenital syphilis--results of a randomised study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8071762" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12050339" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Central nervous system infection in congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8418161" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8551402" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Lumbar puncture in the evaluation of possible asymptomatic congenital syphilis in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8229534" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Neonatal hypoglycemia caused by hypopituitarism in infants with congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11927736" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Survival with hypopituitarism from congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9559711" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Contribution of long-bone radiographs to the management of congenital syphilis in the newborn infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1945608" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Long-bone radiographic abnormalities as a sign of active congenital syphilis in asymptomatic newborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8609122" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Parrot pseudoparalysis of the upper extremities. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8609122" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Parrot pseudoparalysis of the upper extremities. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2584243" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The skeletal manifestations of congenital syphilis. A review of 197 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1245088" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Anemia as the only presenting manifestation of congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5062089" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Hydrops fetalis and congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2626292" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Congenital syphilitic hepatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Sexually Transmitted Infections Treatment Guidelines, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Sexually Transmitted Infections Treatment Guidelines, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29627075" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18208988" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Syphilis is on the increase: the implications for child health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13972609" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Does early treatment prevent dental changes in congenital syphilis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7936771" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Timely diagnosis of congenital infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13446428" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Interstitial keratitis after adequate penicillin therapy; a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4993238" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Manifestations of late congenital syphilis. An analysis of 271 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2215616" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Congenital syphilis presenting in infants after the newborn period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6304215" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Congenital syphilitic deafness--a further review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6304215" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Congenital syphilitic deafness--a further review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6304215" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Congenital syphilitic deafness--a further review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21307823" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8617480" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Diagnosis of congenital syphilis from placental examination: comparison of histopathology, Steiner stain, and polymerase chain reaction for Treponema pallidum DNA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4910820" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Failure of penicillin in a newborn with congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8994751" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Congenital syphilis: detection of Treponema pallidum in stillborns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1669665" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Comparison of maternal and newborn serologic tests for syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21346050" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8486942" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Clinical and serologic evaluation of neonates for congenital syphilis: a continuing diagnostic dilemma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2203809" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Evaluation of the Captia enzyme immunoassays for detection of immunoglobulins G and M to Treponema pallidum in syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27081586" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Current Perspectives on Prevention of Mother-to-Child Transmission of Syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25968492" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Assessment of the impact of rapid syphilis tests on syphilis screening and treatment of pregnant women in Zambia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11460026" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Congenital syphilis and fluorescent treponemal antibody test reactivity after the age of 1 year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2676323" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17151205" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Detection of Treponema pallidum subsp. pallidum from skin lesions, serum, and cerebrospinal fluid in an infant with congenital syphilis after clindamycin treatment of the mother during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31558291" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Congenital syphilis: A prospective study of 22 cases diagnosed by PCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8116709" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Epidemic syphilis: maternal factors associated with congenital infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1652119" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Congenital syphilis: trends and recommendations for evaluation and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8859255" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Problems in the current case definitions of congenital syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7075138" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Osseous manifestations in congenital syphilis: a study of 55 cases.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
